The following new grants were awarded to JCCC members in March 2013:
Principal Investigator: Chiou, Pei-Yu
Sponsor Name: National Science Foundation
Award Title: Development of a High Speed Facs for Sorting BSL3 Infectious Agents
Principal Investigator: De Vos, Sven
Sponsor Name: Janssen Pharmaceuticals, Inc.
Award Title: Phase 2, Multicenter, Single-Arm, Study to Evaluate the Efficacy and Safety of Single-Agent Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Subjects with Mantle Cell Lymphoma Who Progress after Bortezomib therapy
Principal Investigator: Eradat, Herbert
Sponsor Name: Kyowa Pharmaceutical, Inc.
Award Title: Open-Label, Multi-Center, Randomized Study of anti-Ccr4 Monoclonal antibody Kw-0761 (Mogamulizumab) Versus Vorinostat in Subjects with Previously Treated Cutaneous T-Cell Lymphoma
Principal Investigator: Finn, Richard
Sponsor Name: Arqule Inc.
Award Title: Phase 3, Randomized, Double-Blind Study of Tivantinib in Subjects with Met Diagnostic-High Inoperable Hepatocellular Carcinoma Treated with One Prior Systemic therapy
Principal Investigator: Glaspy, John
Sponsor Name: Eli Lilly and Company
Award Title: Randomized Phase 2 Placebo-Controlled Study of Ly2495655 in Patients with Advanced or Metastatic Pancreatic Cancer Receiving Chemotherapy
Principal Investigator: Hurvitz, Sara
Sponsor Name: Translational Research in Oncology (TRIO-US)
Award Title: Phase 1b/2 Single-arm Trial Evaluating the Combination of Lapatinib, Everolimus and Capecitabine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer with CNS Progression after Trastuzumab
Principal Investigator: Kominski, Gerald
Sponsor Name: California Endowment
Award Title: CHIS 2011-2012 Policy Research Studies
Principal Investigator: Marks, Leonard
Sponsor Name: Clarus Therapeutics, Inc.
Award Title: Phase IV, Open Label Study of Oral Testosterone Undercanoate (TU) in Hypogonadal Men
Principal Investigator: Mitsuyasu, Ronald
Sponsor Name: Coalition of Cancer Cooperative Groups
Award Title: PK Interation of Antiretroviral Therapies and Cancer Drugs in AMC Trials
Principal Investigator: Pantuck, Allan
Sponsor Name: Memorial Sloan-Kettering Cancer Center
Award Title: Genomic and Molecular Expression Profile of Metastatic Chromophobe Renal Cell Carcinoma
Principal Investigator: Ponce, Ninez
Sponsor Name: Kaiser Foundation Research Institute
Award Title: California Health Interview Survey (CHIS) 2013-2014 Kaiser Northern California
Principal Investigator: Rao, Jian
Sponsor Name: Cold Genesys, Inc.
Award Title: Oncolytic Adenovirus Expressing GM-CSF for Patients with NMIBC
Principal Investigator: Ribas, Antoni
Sponsor Name: Genentech, Inc.
Award Title: Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Vemurafenib Adjuvant therapy in Patients with Surgically Resected, Cutaneous Braf Mutant Melanoma at High Risk for Recurrence
Principal Investigator: Schiller, Gary
Sponsor Name: Celator Pharmaceuticals, Inc.
Award Title: Phase III, Multicenter, Randomized, Trial of CPX-351 Liposome Injection versus Cytarabine and Daunorubicin in Patients 60 to 75 Years of Age with Untreated High Risk AML
Principal Investigator: Sun, Ren
Sponsor Name: NIH/National Cancer Institute
Award Title: Reactivation of Kaposi's Sarcoma-associated Herpsevirus
Principal Investigator: Van Dam, Robert
Sponsor Name: Sofie Biosciences, Inc.
Award Title: Commercialization of a Novel Pet Probe for Use in Cancer Diagnostics
Sponsor Name: L.A. County Children & Families First
Award Title: Neighborhood Trends in Early Childhood Obesity in Los Angeles County, 2003-2012
Principal Investigator: Work, Anna
Sponsor Name: NIH/Center for Scientific Review
Award Title: Multifunctional Immunopet Tracers for Pancreatic and Prostate Cancer